Naloxone Administration Guidelines
Clinical Scenarios for Naloxone Administration
- The American Heart Association recommends administering naloxone to patients with suspected opioid overdose who have a definite pulse but no normal breathing or only gasping, in addition to providing standard BLS and/or ACLS care 1
- Naloxone should be administered in opioid-associated resuscitative emergencies defined by respiratory arrest, severe CNS or respiratory depression, or life-threatening instability suspected to be due to opioid toxicity 1, 2, 3
Administration Protocol
- The American Heart Association recommends focusing first on supporting the patient's airway and breathing, followed by delivery of rescue breaths, and not delaying activation of emergency response systems while awaiting patient's response to naloxone 1, 2
Post-Administration Care
- Patients should be observed in a healthcare setting until the risk of recurrent opioid toxicity is low, and monitored continuously for at least 2 hours after the last dose of naloxone 1, 5
- The American Heart Association notes that naloxone may precipitate acute withdrawal syndrome in opioid-dependent patients, with symptoms including hypertension, tachycardia, vomiting, and agitation, and recommends minimizing risk by using the lowest effective dose 2, 3
Special Considerations
- Naloxone's duration of action is shorter than many opioids, requiring monitoring for re-sedation, and consider repeat doses or continuous infusion for long-acting opioid overdoses 1, 5
- The American Heart Association states that naloxone has an excellent safety profile when used appropriately, even in non-opioid intoxicated patients 2, 3